Brand Name(s)
Simponi®
Drug Class
Biologics
How taken
Injection under the skin (subcutaneous)
Used for
Moderate-to-severe ulcerative colitis
Recommendations for Pregnancy
No proven risk in humans
Recommendations for Lactation
No human data: probably compatible
Medication indication
Induces and maintains a clinical response in patients with moderate to severe active ulcerative colitis when certain other medications have not worked well enough or cannot be tolerated, or if it is necessary to continue taking steroid medications.
Indicated for pediatric use
NOTE: This medication may be recommended for use in children. Be sure to talk to your doctor about potential risks and side effects.
Most common side effects
Upper respiratory infection such as runny nose, sore throat, hoarseness or laryngitis; injection site reactions such as redness, swelling, itching, pain, bruising and tingling; viral infections such as flu and oral cold sores.
Other
There have been reports of serious infections while taking golimumab, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that spread throughout the body. Lymphoma and other malignancies have been reported in children and adolescent patients treated with TNF blockers, of which golimumab is a member.
To see the full prescribing information for this medication, click here.
Scroll right by clicking & dragging with your cursor or swiping with your finger.